PPCBD
Price:
$0.055
Market Cap:
$180.86K
Propanc Biopharma, Inc., a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. Its lead product is PRP, a formulation that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes. The company has a research collaboration with University of Jaén that undertakes the research activities for POP1 joint drug discovery program; and a joint research and drug discovery program with Universities of Jaén and Granada to investigate the changes in genetic and protein expression that occur in cancer cells. The company was formerly known as Propanc Health Group Corporation and change...[Read more]
Industry
Biotechnology
IPO Date
2012-11-12
Stock Exchange
PNK
Ticker
PPCBD
According to Propanc Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is 63.02%. This represents a change of 171.74% compared to the average of 23.19% of the last 4 quarters.
The mean historical ROE of Propanc Biopharma, Inc. over the last ten years is 104.50%. The current 63.02% ROE has changed -39.70% with respect to the historical average. Over the past ten years (40 quarters), PPCBD's ROE was at its highest in in the June 2020 quarter at 130.19%. The ROE was at its lowest in in the December 2020 quarter at 11.19%.
Average
104.50%
Median
109.05%
Minimum
66.04%
Maximum
133.88%
Discovering the peaks and valleys of Propanc Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 33.11%
Maximum Annual ROE = 133.88%
Minimum Annual Increase = -49.27%
Minimum Annual ROE = 66.04%
Year | ROE | Change |
---|---|---|
2022 | 87.91% | 33.11% |
2021 | 66.04% | -49.27% |
2020 | 130.19% | -2.76% |
The current ROE of Propanc Biopharma, Inc. (PPCBD) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
94.71%
5-year avg
104.50%
10-year avg
104.50%
Propanc Biopharma, Inc.’s ROE is greater than Nouveau Life Pharmaceuticals, Inc. (0%), greater than Kali, Inc. (0%), less than Endonovo Therapeutics, Inc. (15.62%), greater than BioRestorative Therapies, Inc. (-42.90%), greater than Priority Aviation, Inc. (0%),
Company | ROE | Market cap |
---|---|---|
0% | $180.00K | |
0% | $26.56K | |
15.62% | $350.63K | |
-42.90% | $10.38M | |
0% | $7.59K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Propanc Biopharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Propanc Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Propanc Biopharma, Inc.'s ROE?
How is the ROE calculated for Propanc Biopharma, Inc. (PPCBD)?
What is the highest ROE for Propanc Biopharma, Inc. (PPCBD)?
What is the 3-year average ROE for Propanc Biopharma, Inc. (PPCBD)?
What is the 5-year average ROE for Propanc Biopharma, Inc. (PPCBD)?
How does the current ROE for Propanc Biopharma, Inc. (PPCBD) compare to its historical average?